Conf Save Date 2019 1

About the HSRAANZ

Founded in 2001, the Health Services Research Association of Australia & New Zealand (HSRAANZ) supports and promotes the conduct and dissemination of applied research to improve the delivery and organisation of health services in Australia and New Zealand. With a wide range of individual and corporate members from universities, research centres, government departments, independent government agencies, and consumer groups the Association bridges the gap between research and policy, as well as reflecting consumer issues. We also have two special interest groups, focussing on Emerging Researchers and Indigenous Health Services Research, both of which have a prominent role at our main conference. [read more]
Membership Login
First Name:
Last Name:

Member Profile

Our latest member interview is with Hamish Robertson, Senior Research Fellow at the Centre for Health Services Management, Faculty of Health, UTS.  Hamish's research interests are health and medical geography in the fields of health, ageing and disability.

Read More


    • 04 DEC 16

    Kathryn North, Director Murdoch Childrens Research Institute

    Kathryn North, Director of the Murdoch Childrens Research Institute, one of our new corporate members, talks to us about the Centre’s research.

    Read more →
    • 17 NOV 16

    Health Services Research: it won’t cure cancer, but it will get better value from today’s services

    After extensive public consultation with consumers, researchers, healthcare providers and managers, the government last week released two reports from the Australian Medical Research Advisory Board: the Australian Medical Research and Innovation Strategy 2016-2021, and the accompanying Australian Medical Research and Innovation Priorities 2016-2018. The response to the two documents from prominent researchers and peak research bodies has been positive, with the focus on improving health systems and structures particularly welcome.

    In this article originally posted on the Croakey Blog HSRAANZ President Jon Karnon and Professor Nicholas Graves explain why health services research will deliver value for the medical research dollar.

    Read more →
    • 03 NOV 16

    HSRAANZ Annual General Meeting and Symposium – Health Services Research – where to from here? Program now available.

    The full program for the HSRAANZ Symposium is now available. We are pleased to announce that Mark Booth, First Assistant Secretary, Health Systems Policy and Erica Kneipp, Assistant Secretary, Health and Medical Research at the Department of Health will both be presenting at our HSRAANZ Symposium in Canberra on 1 December. They will be joined by 6 of the 7 finalists for HSRAANZ Research Impact Award who will discuss the impact of their research programs. The HSRAANZ President Jon Karnon will talk on Innovation and Implementation and Health Services Research and we will have the preliminary results from our report on the state and potential of HSR in Australia and New Zealand. Don’t miss out on what should be a stimulating event. Book your place now.

    Read more →
    • 03 NOV 16

    Developing primary care that is fit for the future: cross-country comparisons

    The video and slides from our latest webinar on emerging international models of primary care, presented by Professor Judith Smith from the Health Services Management Centre, University of Birmingham are now available to view.

    Read more →
    • 20 OCT 16

    Cancer deaths to cost Ireland €73 billion over the next 20 years

    Researchers at the National Cancer Registry Ireland found that deaths from cancer will result in lost productivity valued at €73 billion; €13 billion in lost paid work and €60 billion in lost unpaid activities. When people die from cancer, society loses their contribution to the economy through paid work and unpaid activities such as housework, caring for relatives and volunteering. This work provides a complementary perspective on the burden of cancer in Ireland, and can be used to inform policy makers and health services about priorities for cancer care and research in the future.

    Read more →
    • 18 OCT 16

    HSRAANZ Annual General Meeting and Symposium – Health Services Research – where to from here? A review of the state and potential of HSR in Australia and New Zealand

    Registrations are now open for the Association’s Annual General Meeting and Symposium – Health Services Research – where to from here? on 1 December 2016 at the National Press Club, Canberra. At the event we will launch the preliminary findings of a commissioned report on the state and potential of HSR in Australia and New Zealand. This will be accompanied by short presentations by leading health services researchers describing the impact of their HSR on the Australian and New Zealand healthcare system and population health. Following the report launch and presentations, we will be holding break-out sessions to discuss the potential role and approaches to HSR in Australia and New Zealand in different sectors of the healthcare system (e.g. public hospitals, primary care, aged care, public health).

    Read more →
    • 18 OCT 16

    HSRAANZ Members – tell us about your research

    We want to encourage and help HSRAANZ members to publicise their research. You can do this simply, by completing our template. All we require is a 500 word summary for the HSRAANZ Blog, a 100 word summary for the HSRAANZ email newsletter and a 140 character summary for @hsraanz so that we can tweet about the paper and share a link to the blog. You can also post a photo of yourself or your team. For an example of how this can be done take a look at the post below “When newer isn’t better: We’re paying too much for patented pharmaceuticals” which looks at the latest research from our President, Jon Karnon

    Read more →
    • 18 OCT 16

    When newer isn’t better: We’re paying too much for patented pharmaceuticals.

    New pharmaceuticals are often listed on the Pharmaceutical Benefits Schedule at the same price as an equivalent pharmaceutical. Analysis of denosumab for the treatment of osteoporosis shows that the government has been paying almost $250,000 to gain the equivalent of one additional quality adjusted life year (QALY) since its comparator, alendronate went off patent. The Australian government should review listed pharmaceuticals as their comparator comes off patent to reflect the lower price of the comparator as well as any new clinical and economic data.

    Read more →
Skip to toolbar